ABSTRACT
Importance Early morning blood draws disrupt patients’ sleep and adversely affect patient experience.
Objective To describe the trends in non-urgent early morning blood draws in a large health care system.
Design This cross-sectional study analyzed trends in non-urgent early morning (04:00–06:59) blood draws using the electronic medical records of patients hospitalized between November 2016 and October 2019.
Setting The study was done at Yale New Haven Health System, which is Connecticut’s largest health care system consisting of 5 hospitals.
Participants We included all blood draw events for hospitalized adult patients (≥18 years at the time of admission).
Main outcome and measures We assessed the timing of non-urgent (excluding blood draws performed in the emergency department, critical care units, step-down units, and during the first 24 hours of admission) blood draws among hospitalized patients and determined if the trends of early morning (04:00–06:59) blood draws varied by patient characteristics or over the study duration.
Results Of the 5,676,802 blood draw events included, 38.9% occurred between 04:00–06:59 with only modest differences across age, race and ethnicity, and gender subgroups. The proportion of early morning blood draws increased over the study period from 36.9% to 41.4% (P<0.001). Of the early morning samples, those collected between 04:00–04:59 decreased from 25.6% to 18.5%, those collected between 05:00–05:59 increased from 39.6% to 45.5%, and those collected between 06:00–06:59 increased from 34.6% to 36.0% (P<0.001, each).
Conclusions and relevance The proportion of non-urgent early morning blood draws was persistently high over 3 years. There is a need to redesign hospital care to reduce sleep interruptions from non-urgent interventions.
Question What are the trends in non-urgent early morning (04:00–06:59) blood draws among non-critically ill hospitalized patients across a large health care system?
Findings This cross-sectional study showed that 38.9% of all blood draws occurred between 04:00–06:59, with only modest differences across age, race and ethnicity, and gender subgroups. The proportion of early morning blood draws increased over the study period from 36.9% to 41.4% (P<0.001).
Meaning The proportion of non-urgent early morning blood draws remains persistently high, suggesting a need to redesign hospital care to reduce sleep interruptions from non-urgent interventions.
Competing Interest Statement
In the past three years, Harlan Krumholz received expenses and/or personal fees from UnitedHealth, Element Science, Aetna, Reality Labs, Tesseract/4Catalyst, F-Prime, the Siegfried and Jensen Law Firm, Arnold and Porter Law Firm, and Martin/Baughman Law Firm. He is a co-founder of Refactor Health and HugoHealth, and is associated with contracts, through Yale New Haven Hospital, from the Centers for Medicare & Medicaid Services and through Yale University from Johnson & Johnson. Bobak Mortazavi received expenses and/or personal fees from HugoHealth, as a consultant. Dr. Khera receives support from the National Heart, Lung, and Blood Institute of the National Institutes of Health under award, 1K23HL153775, and is a founder of Evidence2Health, a precision health and digital health analytics platform. The other co-authors report no potential conflicts of interest.
Funding Statement
This study did not receive external funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board at Yale University waived ethical approval for this work, deeming it exempted from review as we used de-identified information.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study may be available upon reasonable request to the authors.
